While Express Scripts (NASDAQ:ESRX), the largest pharmacy benefit manager in the country, has a firm grip on its industry, investors have been more concerned with getting a grip on the company's prospects for the future, especially after a negative outlook sent shares south late last year. In the following video, Motley Fool health care bureau chief quickly runs through his assessment of Express Scripts' guidance and discusses a few tailwinds and headwinds facing the company in the near future.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends Express Scripts and UnitedHealth Group. The Motley Fool owns shares of Express Scripts. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
